LINC01135: A Drug Target / Disease Biomarker (G100131060)

Target Name: LINC01135

NCBI ID: G100131060

LINC01135

Other Name(s): long intergenic non-protein coding RNA 1135 | Long intergenic non-protein coding RNA 1135, transcript variant 1

LINC01135: A Drug Target / Disease Biomarker

LINC01135 is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Its name, LINC01135, comes from the words lymph node, inception, and 5, suggesting that it is involved in the development and maintenance of lymph nodes, which play a critical role in the immune system.

LINC01135 is a non-coding RNA molecule that is expressed in a variety of tissues and cells throughout the body. It is a key regulator of the immune response, and it has been shown to play a role in the regulation of T cell development and function.

One of the most promising aspects of LINC01135 is its potential as a drug target. LINC01135 has been shown to interact with a variety of protein molecules, including the T cell receptor alpha chain (TCR伪), which is a critical receptor for T cells that is involved in cell survival and division.

In addition to its potential as a drug target, LINC01135 has also been shown to be a potential biomarker for a variety of diseases. For example, it has been shown to be downregulated in the brains of individuals with depression, and it has been shown to be elevated in the brains of individuals with Alzheimer's disease.

These findings suggest that LINC01135 may be a useful tool for the development of new treatments for a variety of psychiatric and neurological disorders. However, more research is needed to fully understand its potential and to determine its exact role in the immune system and in the development of various diseases.

In conclusion, LINC01135 is a gene that has the potential to be a drug target and biomarker for a variety of diseases. Its interactions with the T cell receptor alpha chain and its potential as a regulator of the immune system make it an attractive candidate for further research. Further studies are needed to fully understand its potential and to determine its exact role in the immune system and in the development of various diseases.

Protein Name: Long Intergenic Non-protein Coding RNA 1135

The "LINC01135 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01135 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets